Research ExplorerPublicationsVom Kompetenznetz Hepatitis (HepNet) zur Deutschen Leberstif...

Vom Kompetenznetz Hepatitis (HepNet) zur Deutschen Leberstiftung

Standard

Vom Kompetenznetz Hepatitis (HepNet) zur Deutschen Leberstiftung. / Hardtke, S; Wiebner, B; Manns, M P.

In: BUNDESGESUNDHEITSBLA, Vol. 59, No. 4, 04.2016, p. 482-8.

Research output: SCORING: Contribution to journal › SCORING: Journal article › Research

Harvard

Hardtke, S, Wiebner, B & Manns, MP 2016, 'Vom Kompetenznetz Hepatitis (HepNet) zur Deutschen Leberstiftung', BUNDESGESUNDHEITSBLA, vol. 59, no. 4, pp. 482-8. https://doi.org/10.1007/s00103-016-2319-6

APA

Hardtke, S., Wiebner, B., & Manns, M. P. (2016). Vom Kompetenznetz Hepatitis (HepNet) zur Deutschen Leberstiftung. BUNDESGESUNDHEITSBLA, 59(4), 482-8. https://doi.org/10.1007/s00103-016-2319-6

Vancouver

Hardtke S, Wiebner B, Manns MP. Vom Kompetenznetz Hepatitis (HepNet) zur Deutschen Leberstiftung. BUNDESGESUNDHEITSBLA. 2016 Apr;59(4):482-8. https://doi.org/10.1007/s00103-016-2319-6

Bibtex

@article{246934cabb2a4a799b1256d5c528cc03,
title = "Vom Kompetenznetz Hepatitis (HepNet) zur Deutschen Leberstiftung",
abstract = "The competence network for viral hepatitis (HepNet) was founded in 2002 with funding from the German government and has influenced the research on viral hepatitis in Germany. HepNet collaborator sites have been involved in numerous national and international investigator-initiated, as well as industry-sponsored, phase 1-3 studies. Within the HepNet Study-House, many groundbreaking investor-initiated trials have been completed and are still ongoing. For example, the acute hepatitis C trials and trials on chronic hepatitis D (delta), which led to therapy optimization. Continuation of the competence network on viral hepatitis has been achieved by the foundation of the German Liver Foundation, which has been an external cooperation partner of the German Center for Infection Research (DZIF) for two years. The well-established HepNet Study-House acts here as the clinical trial platform for all DZIF hepatitis trials. ",
keywords = "Biomedical Research/organization & administration, Clinical Competence, Clinical Trials as Topic/organization & administration, Foundations/organization & administration, Gastroenterology/organization & administration, Germany/epidemiology, Government Programs/organization & administration, Hepatitis, Viral, Human/epidemiology, Humans, Interinstitutional Relations, Models, Organizational, National Health Programs/organization & administration, Program Evaluation, Quality Assurance, Health Care/organization & administration",
author = "S Hardtke and B Wiebner and Manns, {M P}",
year = "2016",
month = apr,
doi = "10.1007/s00103-016-2319-6",
language = "Deutsch",
volume = "59",
pages = "482--8",
journal = "BUNDESGESUNDHEITSBLA",
issn = "1436-9990",
publisher = "Springer",
number = "4",

}

RIS

TY - JOUR

T1 - Vom Kompetenznetz Hepatitis (HepNet) zur Deutschen Leberstiftung

AU - Hardtke, S

AU - Wiebner, B

AU - Manns, M P

PY - 2016/4

Y1 - 2016/4

N2 - The competence network for viral hepatitis (HepNet) was founded in 2002 with funding from the German government and has influenced the research on viral hepatitis in Germany. HepNet collaborator sites have been involved in numerous national and international investigator-initiated, as well as industry-sponsored, phase 1-3 studies. Within the HepNet Study-House, many groundbreaking investor-initiated trials have been completed and are still ongoing. For example, the acute hepatitis C trials and trials on chronic hepatitis D (delta), which led to therapy optimization. Continuation of the competence network on viral hepatitis has been achieved by the foundation of the German Liver Foundation, which has been an external cooperation partner of the German Center for Infection Research (DZIF) for two years. The well-established HepNet Study-House acts here as the clinical trial platform for all DZIF hepatitis trials.

AB - The competence network for viral hepatitis (HepNet) was founded in 2002 with funding from the German government and has influenced the research on viral hepatitis in Germany. HepNet collaborator sites have been involved in numerous national and international investigator-initiated, as well as industry-sponsored, phase 1-3 studies. Within the HepNet Study-House, many groundbreaking investor-initiated trials have been completed and are still ongoing. For example, the acute hepatitis C trials and trials on chronic hepatitis D (delta), which led to therapy optimization. Continuation of the competence network on viral hepatitis has been achieved by the foundation of the German Liver Foundation, which has been an external cooperation partner of the German Center for Infection Research (DZIF) for two years. The well-established HepNet Study-House acts here as the clinical trial platform for all DZIF hepatitis trials.

KW - Biomedical Research/organization & administration

KW - Clinical Competence

KW - Clinical Trials as Topic/organization & administration

KW - Foundations/organization & administration

KW - Gastroenterology/organization & administration

KW - Germany/epidemiology

KW - Government Programs/organization & administration

KW - Hepatitis, Viral, Human/epidemiology

KW - Humans

KW - Interinstitutional Relations

KW - Models, Organizational

KW - National Health Programs/organization & administration

KW - Program Evaluation

KW - Quality Assurance, Health Care/organization & administration

U2 - 10.1007/s00103-016-2319-6

DO - 10.1007/s00103-016-2319-6

M3 - SCORING: Zeitschriftenaufsatz

C2 - 26942931

VL - 59

SP - 482

EP - 488

JO - BUNDESGESUNDHEITSBLA

JF - BUNDESGESUNDHEITSBLA

SN - 1436-9990

IS - 4

ER -